Your English writing platform
Discover LudwigSuggestions(1)
Exact(5)
Three subjects died in the Advantage trial; five more subjects experienced heart attacks.
The ADVANTAGE trial (ClinicalTrials.gov identifier NCT00705016) is a phase I/II, multicentre study in patients with recurrent and/or metastatic SCCHN.
The ADVANTAGE trial investigated cilengitide (CIL; integrin inhibitor) + cisplatin/5-fluorouracil/cetuximab (PFE) in recurrent/metastatic squamous cell cancer of the head/neck.
The phase II part of the ADVANTAGE trial was a multicenter, open-label, randomized, controlled study investigating cilengitide 2000 mg once (CIL1W) or twice (CIL2W) weekly plus PFE versus PFE alone (ClinicalTrials.gov NCT00705016 [EMR 200052-013]).
This confirms the safety findings of the dose-finding phase I part of the ADVANTAGE trial [ 9] and is consistent with the favorable tolerability to cilengitide previously observed in glioblastoma multiforme patients [ 11– 13].
Similar(55)
TAKE ADVANTAGE of trial periods, often 15 or 30 days.
The way the government has proceeded with the effort, the filing states, leaves "scant doubt that it is seeking to obtain just such an improper advantage at trial".
Federal agents made false statements to the press; submitted false affidavits to courts; coerced alleged witness statements; and deliberately withheld critical ballistics reports in order to gain an unfair advantage at trial.
Scores on all other domains were either not statistically significantly different between the two samples or showed a statistically significant advantage for trial patients.
In multivariate analyses of patients diagnosed during 1985–1994 that also included age, sex, primary site, surgical treatment centre, the results relating to main treatment centre for both OS and ES retained significance but the survival advantage of trial entry for ES became nonsignificant.
Be sure to take advantage of trial memberships when choosing a facility.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com